PLA2G4A and ischemic stroke: Importantly, both activity and expression levels of PLA2G4A were increased in neurodegenerative diseases, traumatic brain injury (TBI) and ischemic stroke, and implicated in neuronal cell death 21, making it an attractive target for therapeutic intervention.